KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway
International Journal of Biological Sciences · 2024 · 20 (1) · 387-402
DOI: 10.7150/ijbs.86385 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Zhicheng Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin,150001, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Colon adenocarcinoma (COAD) is the most common malignancy of the digestive tract, which is characterized by a dismal prognosis. No effective treatment has been established presently, thus there is an urgent need to understand the mechanisms driving COAD progression in order to develop effective therapeutic approaches and enhance clinical outcomes. In this study, we found that KLF7 is overexpressed in COAD tissues and correlated with clinicopathological features of COAD. Both gain-of-function and loss-of-function experiments have unequivocally demonstrated that overexpression of KLF7 promotes the growth and metastasis of COAD in vitro and in vivo, while KLF7 knockdown attenuated these effects. Mechanistically, our findings reveal that KLF7 can specifically bind to the promoter region of PDGFB (TGGGTGGAG), thus promoting the transcription of PDGFB and increasing its secretion. Subsequently, secreted PDGFB facilitates the progression of COAD by activating MAPK/ERK, PI3K/AKT, and JAK/STAT3 signaling pathways through PDGFRβ. Additionally, we found that sunitinib can block PDGFB signaling and inhibit COAD progression, offering a promising therapeutic strategy for COAD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin,150001, China.
- Bio-Bank of Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
- Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, 150001, China.
- Editorial Board of Harbin Medical University, Harbin Medical University, Harbin 150001, China.
- School of Medicine and Health, Harbin Institute of Technology, Harbin, 150001, China.
- Heilongjiang Key Laboratory of Children Development and Genetic Research, Harbin Medical University, Harbin,150001, China.
Zitieren
APA
Zhang, Z., Jiang, X., Li, K., Qiao, S., Li, M., Mei, Y., Ding, L., Lv, Q., Ding, Y., Zhao, Y., Lv, G., Tan, G., Yang, H., Li, G., Gao, X., & Liu, M. (2024). KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway. International Journal of Biological Sciences, 20(1), 387-402. https://doi.org/10.7150/ijbs.86385
Vancouver
Zhang Z, Jiang X, Li K, Qiao S, Li M, Mei Y, et al. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway. International Journal of Biological Sciences. 2024;20(1):387-402. doi:10.7150/ijbs.86385
BibTeX
@article{Zhang2024,
author = {Zhang, Zhicheng and Jiang, Xiaochen and Li, Kai and Qiao, Shupei and Li, Mengmeng and Mei, Yu and Ding, Lixian and Lv, Qiang and Ding, Yike and Zhao, Yunhan and Lv, Guixiang and Tan, Gang and Yang, Huanjie and Li, Guodong and Gao, Xu and Liu, Ming},
title = {KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {1},
pages = {387--402},
doi = {10.7150/ijbs.86385}
}
EUVIMED